GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Nidan Laboratories and Healthcare Ltd (NSE:NIDAN) » Definitions » Change In Receivables

Nidan Laboratories and Healthcare (NSE:NIDAN) Change In Receivables : ₹52.5 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Nidan Laboratories and Healthcare Change In Receivables?

Nidan Laboratories and Healthcare's change in receivables for the quarter that ended in Mar. 2024 was ₹0.0 Mil. It means Nidan Laboratories and Healthcare's Accounts Receivable stayed the same from Mar. 2023 to Mar. 2024 .

Nidan Laboratories and Healthcare's change in receivables for the fiscal year that ended in Mar. 2024 was ₹-203.1 Mil. It means Nidan Laboratories and Healthcare's Accounts Receivable increased by ₹203.1 Mil from Mar. 2023 to Mar. 2024 .

Nidan Laboratories and Healthcare's Accounts Receivable for the quarter that ended in Mar. 2024 was ₹5.2 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Nidan Laboratories and Healthcare's liquidation value for the six months ended in Mar. 2024 was ₹-129.5 Mil.


Nidan Laboratories and Healthcare Change In Receivables Historical Data

The historical data trend for Nidan Laboratories and Healthcare's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nidan Laboratories and Healthcare Change In Receivables Chart

Nidan Laboratories and Healthcare Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Change In Receivables
Get a 7-Day Free Trial -22.72 -72.65 -4.86 52.54 -203.06

Nidan Laboratories and Healthcare Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Mar24
Change In Receivables Get a 7-Day Free Trial - - -3.80 56.34 -

Nidan Laboratories and Healthcare Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹52.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nidan Laboratories and Healthcare  (NSE:NIDAN) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Nidan Laboratories and Healthcare's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=5.244/0*91
=

2. In Ben Graham's calculation of liquidation value, Nidan Laboratories and Healthcare's accounts receivable are only considered to be worth 75% of book value:

Nidan Laboratories and Healthcare's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=28.499-163.447+0.75 * 5.244+0.5 * 3.019
=-129.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nidan Laboratories and Healthcare Change In Receivables Related Terms

Thank you for viewing the detailed overview of Nidan Laboratories and Healthcare's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Nidan Laboratories and Healthcare Business Description

Traded in Other Exchanges
N/A
Address
Vartak Road, SY No. 294/A H. No. 18, Swapnshilpa Bunglow, Behind Aarti Apartment, Virar West, Palghar, Virar, MH, IND, 401303
Nidan Laboratories and Healthcare Ltd offer diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to radiology tests including computerized tomography scans, magnetic resonance imaging scans.

Nidan Laboratories and Healthcare Headlines

No Headlines